The Cutting Edge of Medical Technology Content, Community & Collaboration
A decade ago there was much hope and hype for gene therapy. Then came the death of Jesse Gelsinger , an 18 year old, as a result of uncontrolled infection from the viral vector used to insert the gene change. That led to a near total stop of gene therapy clinical trials and the development of multiple new regulations, especially multiple levels of extensive reviews.
Now some new developments are coming to fruition and there is some legitimate reason for enthusiasm that gene therapy…
ContinueAdded by Stephen C Schimpff on January 3, 2012 at 5:22pm — No Comments
© 2024 Created by CC-Conrad Clyburn-MedForeSight. Powered by